Image from ProQuestFrom Live Science:
The federal government has approved the first study by a company that will use human embryonic stem cells injected into a human.
The Geron corporation announce the approval today. The therapy used in the study is designed to treat spinal cord injuries by injecting stem cells — which are able to transform into the many different types of cells we need in our bodies — directly into the patients' spinal cords.
The U.S. Food and Drug Administration (FDA) granted clearance of the company's application for the clinical trial of GRNOPC1 in patients with acute spinal cord injury.
"This marks the beginning of what is potentially a new chapter in medical therapeutics - one that reaches beyond pills to a new level of healing: the restoration of organ and tissue function achieved by the injection of healthy replacement cells," said Geron's president and CEO. Dr. Thomas B. Okarma.
Read more ....
No comments:
Post a Comment